BACKGROUND: Thoracic aortic dissection (TAD) is characterized by dysregulated extracellular matrix. Little is known about the alterations of collagen and stimulators of collagen synthesis, eg, connective tissue growth factor (CTGF), in patients with TAD. In this study, we examined their roles in TAD. METHODS AND RESULTS: Surgical specimens of the aortic wall of TAD patients (n=10) and controls (n=10) were tested for collagen types I and III and CTGF expression. When compared with controls, protein levels of type I and III collagen and CTGF were significantly increased by 3.2-, 3.7-, and 5.3-fold, respectively (P<0.05 for all). Similar patterns were shown in mRNA levels of type Ialpha and Ialpha2 collagen and CTGF. Using immunohistochemistry and trichrome staining, we also observed elevated levels of collagen in the aortic media and adventitia. Treatment with recombinant human CTGF increased collagen synthesis in cultured aortic smooth muscle cells in a dose- and time-dependent fashion, in which expression of collagens increased from 506+/-108 counts per minute to 2764+/-240 cpm by 50 ng/mL CTGF, and from 30+/-43 cpm to 429+/-102 cpm at 48 hours. CONCLUSIONS: TAD patients exhibited significantly increased expression of aortic collagen types I and III as well as CTGF, which is likely to be responsible for the compromised aortic distensibility and systemic compliance. Because CTGF can increase collagen expression, CTGF may be a new target molecule in the pathogenesis and progression of TAD.
BACKGROUND: Thoracic aortic dissection (TAD) is characterized by dysregulated extracellular matrix. Little is known about the alterations of collagen and stimulators of collagen synthesis, eg, connective tissue growth factor (CTGF), in patients with TAD. In this study, we examined their roles in TAD. METHODS AND RESULTS: Surgical specimens of the aortic wall of TAD patients (n=10) and controls (n=10) were tested for collagen types I and III and CTGF expression. When compared with controls, protein levels of type I and III collagen and CTGF were significantly increased by 3.2-, 3.7-, and 5.3-fold, respectively (P<0.05 for all). Similar patterns were shown in mRNA levels of type Ialpha and Ialpha2 collagen and CTGF. Using immunohistochemistry and trichrome staining, we also observed elevated levels of collagen in the aortic media and adventitia. Treatment with recombinant humanCTGF increased collagen synthesis in cultured aortic smooth muscle cells in a dose- and time-dependent fashion, in which expression of collagens increased from 506+/-108 counts per minute to 2764+/-240 cpm by 50 ng/mL CTGF, and from 30+/-43 cpm to 429+/-102 cpm at 48 hours. CONCLUSIONS: TAD patients exhibited significantly increased expression of aortic collagen types I and III as well as CTGF, which is likely to be responsible for the compromised aortic distensibility and systemic compliance. Because CTGF can increase collagen expression, CTGF may be a new target molecule in the pathogenesis and progression of TAD.
Authors: Otto Rahkonen; Ming Su; Harri Hakovirta; Ilpo Koskivirta; Sheriar G Hormuzdi; Eero Vuorio; Paul Bornstein; Risto Penttinen Journal: Circ Res Date: 2003-11-20 Impact factor: 17.367
Authors: Joseph E Pichamuthu; Julie A Phillippi; Deborah A Cleary; Douglas W Chew; John Hempel; David A Vorp; Thomas G Gleason Journal: Ann Thorac Surg Date: 2013-09-07 Impact factor: 4.330
Authors: Cheng Zhang; Ming-Xiang Zhang; Ying H Shen; Jared K Burks; Xiao-Nan Li; Scott A LeMaire; Koichi Yoshimura; Hiroki Aoki; Masunori Matsuzaki; Feng-Shuang An; David A Engler; Risë K Matsunami; Joseph S Coselli; Yun Zhang; Xing Li Wang Journal: Biochim Biophys Acta Date: 2008-03-29
Authors: Selda Sherifova; Gerhard Sommer; Christian Viertler; Peter Regitnig; Thomas Caranasos; Margaret Anne Smith; Boyce E Griffith; Ray W Ogden; Gerhard A Holzapfel Journal: Acta Biomater Date: 2019-08-26 Impact factor: 8.947
Authors: Alkiviadis Tsamis; Julie A Phillippi; Ryan G Koch; Patrick G Chan; Jeffrey T Krawiec; Antonio D'Amore; Simon C Watkins; William R Wagner; David A Vorp; Thomas G Gleason Journal: J Thorac Cardiovasc Surg Date: 2016-02-13 Impact factor: 5.209
Authors: Rishi Kundi; Scott T Hollenbeck; Dai Yamanouchi; Brad C Herman; Rachel Edlin; Evan J Ryer; Chunjie Wang; Shirling Tsai; Bo Liu; K Craig Kent Journal: Cardiovasc Res Date: 2009-07-01 Impact factor: 10.787
Authors: Thomas H Petersen; Thomas Hitchcock; Akihito Muto; Elizabeth A Calle; Liping Zhao; Zhaodi Gong; Liqiong Gui; Alan Dardik; Dawn E Bowles; Christopher M Counter; Laura E Niklason Journal: Cell Transplant Date: 2009-10-29 Impact factor: 4.064